Velaprumig

• Description :

  Velaprumig is a monoclonal antibody targeting human CD99, CCL25, and anti-human Aβ (Aβ-47F) . Velaprumig regulates immune cell migration and reduces β-amyloid-related pathological processes, exerting immunomodulatory and potential anti - Alzheimer's disease activities[1].

• UNSPSC :

  12352203

• Target :

  Amyloid-β; CCR

• Related Pathways :

  GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling

• Applications :

  Neuroscience-Neurodegeneration

• Field of Research :

  Inflammation/Immunology; Neurological Disease

• Smiles :

  [Velaprumig]

• References & Citations :

  [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• CAS Number :

  [2988741-17-7]